(Q35680560)

9 August 2017

1 reference

title

Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs (English)

1 reference

9 August 2017

1 reference

3

Béatrice Desvergne

0 references

author name string

Nguan Soon Tan

series ordinal

1

1 reference

9 August 2017

Liliane Michalik

series ordinal

2

1 reference

9 August 2017

Walter Wahli

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Expert Opinion on Therapeutic Targets

9 August 2017

1 reference

9 August 2017

8

1 reference

9 August 2017

39-48

1 reference

9 August 2017

1

1 reference

Wound healing--aiming for perfect skin regeneration

9 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Function and regulation of AP-1 subunits in skin physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Peroxisome proliferator-activated receptors in inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Nuclear receptors and the control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Regulation of gene expression by the proto-oncogene BCL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Sphingolipid mediators in cardiovascular cell biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

How cells read TGF-beta signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

A novel pathway of prostacyclin signaling-hanging out with nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

21 January 2018

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Targeted somatic mutagenesis in mouse epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.1.39

21 January 2018

Identifiers

DOI

10.1517/14728222.8.1.39

1 reference

9 August 2017

1 reference